A radioimmunoassay for measurement of 3,3′-diiodothyronine sulfate: studies in thyroidal and nonthyroidal diseases, pregnancy, and fetal/neonatal life
I.J. Chopra A radioimmunoassay for measurement of 3,3′-diiodothyronine sulfate studies in thyroidal and nonthyroidal diseases, pregnancy, and fetal/neonatal life Metabolism 53 2004 538 543
Urinary compound W in pregnant women is a potential marker for fetal thyroid function
S.Y. Wu D.A. Fisher W.S. Huang Urinary compound W in pregnant women is a potential marker for fetal thyroid function Am J Obstet Gynecol 178 1998 886 889
Establishment of the sulfated 3,3′-diiodothyronine radioimmunoassay and its application in pregnant women
W.S. Huang C.S. Roan S.W. Kou Establishment of the sulfated 3,3′-diiodothyronine radioimmunoassay and its application in pregnant women Proc Natl Sci Counc Repub China B 19 1995 201 207
A T2S crossreactive material (compound W) in hyperthyroid patients with trophoblastic disease
Å. Rajatanvin D.A. Fisher I. Chailurkit A T2S crossreactive material (compound W) in hyperthyroid patients with trophoblastic disease Thyroid 9 1999 989 994
Antenatal diagnosis and treatment of fetal goitrous hypothyroidism: Case report and review of the literature
A.Z. Abuhamad D.A. Fisher S.I. Warsoff Antenatal diagnosis and treatment of fetal goitrous hypothyroidism Case report and review of the literature Ultrasound Obstet Gynecol 19 1995 501 505
Maternal compound W serial measurements for the management of fetal hypothyroidism
D. Cortelazzi P.S. Morpurgo P. Zamperini Maternal compound W serial measurements for the management of fetal hypothyroidism Eur J Endocrinol 141 1999 570 578
L. VanMiddlesworth S.M. Guerra B.M. Mercer Maternal “compound W”, a possible indicator of fetal thyroid function during maternal hyperthyroidism on PTU therapy 1995 Program of the 11th International Thyroid Congress, Toronto, Canada, September 10–15 (abstr 211)